MDxHealth SA revised revenue guidance for the fiscal year 2022. For the period, the company expects revenue guidance to be $36.5 million - $37.5 million from $40 million - $42 million.
MDxHealth SA Euronext Bruxelles
Equities
MDXH
BE0974461940
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+22.81% | 46.81B | |
+46.96% | 41.29B | |
-1.88% | 41.37B | |
-6.20% | 28.87B | |
+11.33% | 26.06B | |
-21.00% | 19.13B | |
-1.43% | 11.96B | |
+30.73% | 12.39B | |
-0.48% | 12.08B |